World's First Case: China Achieves Regenerated Islet Transplantation, Opening New Pathway for Diabetes Treatment

2026-03-17 09:10:21

People’s Financial News, March 17 — According to reports from the Chinese Academy of Sciences’ Center for Excellence in Molecular Cell Science (Institute of Biochemistry and Cell Biology), the Cheng Xin research team at the center, in collaboration with Professor Yin Hao’s team from the Second Affiliated Hospital of Naval Medical University (Shanghai Changzheng Hospital), recently achieved the world’s first minimally invasive transplantation of regenerative islets (E-islet) derived from autologous and allogeneic stem cells. This breakthrough has enabled the reconstruction of islet function and autonomous blood sugar regulation in type 1 diabetes patients. The related findings have been published online in the international academic journal The Lancet Diabetes & Endocrinology. (CCTV News)

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.